BACKGROUND: In China, the @entity1544 is the most common @entity5 type, and Mckeown esophagectomy (ME) is preferably adopted by thoracic surgeon. But, the surgical @entity130 of ME is great. Thoracolaparoscopic esophagectomy (TE) was developed to decrease the operative stress; however, the safety and efficacy were not defined. In this study, clinical outcomes were compared between @entity1 who received ME and TE. METHODS: The data of 113 @entity1 who suffered from @entity418 during the same period were collected. Sixty-two @entity1 received ME (ME group), and 51 @entity1 received TE (TE group). @entity1 ' demographics and short-term clinicopathologic outcomes were comparable between the two groups. Survival rate was estimated using the Kaplan-Meier method, and comparisons between groups were performed with log-rank test. RESULTS: @entity1 in TE group had lower body mass index (BMI). @entity5 stage in TE group was much earlier. Both overall and thoracic operation time were longer in TE group. The @entity190 during operation and postoperative day ( @entity773 was less in TE group, which contributed to the less blood transfusion. In TE group, postoperative incidence of @entity358 and @entity955 (p   =   0.035 and p   =   0.033) was lower; the inflammatory response and incision @entity158 were significantly alleviated; the ICU and in-hospital stay was shorter as well because of less surgical @entity130 . No statistically significant difference was found between two groups in terms of overall survival or disease-free survival. CONCLUSIONS: The efficacy and safety of TE were supported by the selected @entity1 in this cohort study. Although it is lack of randomness in this research, some advantages of TE were gratifying such as @entity260 and similar survival with ME. A multicenter prospective randomized study is now required.

Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'Preoperative tumor'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity773 :: ('79585', 'Gene') :: ['POD) 1'] @entity260 :: ('MESH:D011183', 'Disease') :: ['lower postoperative complications'] @entity1544 :: ('MESH:D018307', 'Disease') :: ['middle esophageal squamous cell cancer'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary complications'] @entity418 :: ('MESH:D004938', 'Disease') :: ['middle-thoracic esophageal cancer'] @entity955 :: ('MESH:D001281', 'Disease') :: ['atrial fibrillation'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity130 :: ('MESH:D014947', 'Disease') :: ['trauma']
@entity418 :: (MESH:D004938,Disease) :: ['middle esophageal cancer']
